(18)F-PSMA-1007 PET in Biochemical Recurrent Prostate Cancer: An Updated Meta-Analysis

BACKGROUND: Prostate-specific membrane antigen- (PSMA-) targeted agents labeled with fluorine-18 ((18)F) have recently become available to evaluate patients with biochemical recurrent prostate cancer (BRPCa) by using positron emission tomography/computed tomography (PET/CT) or positron emission tomo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrari, Matteo, Treglia, Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710160/
https://www.ncbi.nlm.nih.gov/pubmed/35002568
http://dx.doi.org/10.1155/2021/3502389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710160/
https://www.ncbi.nlm.nih.gov/pubmed/35002568
http://dx.doi.org/10.1155/2021/3502389

Ejemplares similares